European Union’s drug regulator green lights Pfizer’s COVID-19 pill
The European Union’s drug regulator on Thursday conditionally approved the use of Pfizer Inc’s antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after … Read more